COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis

BACKGROUND: The humoral response to vaccination in individuals with lymphoid malignancies or those undergoing anti-CD20 antibody therapy is impaired, but details of the response to mRNA vaccines to protect against COVID-19 remain unclear. This systematic review and meta-analysis aimed to characteriz...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Yusuke, Honda, Akira, Kurokawa, Mineo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Original Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958822/
https://www.ncbi.nlm.nih.gov/pubmed/35459624
http://dx.doi.org/10.1016/j.clml.2022.03.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958822/
https://www.ncbi.nlm.nih.gov/pubmed/35459624
http://dx.doi.org/10.1016/j.clml.2022.03.012

Ejemplares similares